For the quarter ending 2025-09-30, OMDA had -$24,519K decrease in cash & cash equivalents over the period. $9,596K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -3,178 | -14,759 |
| Depreciation and amortization | 1,359 | 2,685 |
| Share-based compensation | 3,536 | 5,674 |
| Loss on debt extinguishment | -2,109 | - |
| Loss on disposal of property and equipment | 0 | -2 |
| Amortization of debt issuance costs | 33 | 252 |
| Non-cash operating lease expense | 65 | 382 |
| Change in fair value of warrants | 212 | 1,256 |
| Provision for credit losses | 995 | 490 |
| Amortization of deferred commissions | 906 | 1,561 |
| Accounts receivable | 9,154 | 10,360 |
| Inventory | -321 | 173 |
| Prepaid expenses and other current assets | 700 | 870 |
| Deferred commissions | 896 | 1,423 |
| Other non-current assets | -63 | -118 |
| Accounts payable | 357 | 1,016 |
| Operating lease liabilities | 0 | -415 |
| Accrued expenses and other current liabilities | 12,562 | -4,780 |
| Deferred revenue | 1,632 | 5,995 |
| Other non-current liabilities | -89 | 89 |
| Net cash used in operating activities | 10,133 | -13,260 |
| Purchases of property and equipment | 537 | 586 |
| Capitalized internal-use software costs | 1,450 | 1,913 |
| Net cash used in investing activities | -1,987 | -2,499 |
| Proceeds from exercise of stock options | 2,085 | 3,908 |
| Payment of deferred offering costs | 2,357 | 1,927 |
| Repayment of debt principal | 30,963 | - |
| Payment of debt extinguishment costs | 1,430 | - |
| Proceeds from initial public offering, net of underwriting discounts and commissions | 0 | 160,532 |
| Net cash provided by (used in) financing activities | -32,665 | 162,513 |
| Net increase (decrease) in cash and cash equivalents | -24,519 | 146,754 |
| Cash and cash equivalents at beginning of period | 76,392 | - |
| Cash and cash equivalents at end of period | 198,627 | - |
Omada Health, Inc. (OMDA)
Omada Health, Inc. (OMDA)